| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8922417 | Clinical and Translational Radiation Oncology | 2018 | 7 Pages |
Abstract
The results indicate that development of diabetes during high-dose glucocorticoid therapy needing insulin treatment in patients with MSCC from different primary tumors is associated with reduced survival.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Helga Schultz, Ulrik Pedersen-Bjergaard, Andreas Kryger Jensen, Svend Aage Engelholm, Peter Lommer Kristensen,